newsfilter
← Latest News
GlobeNewswire·

Impel Pharmaceuticals Announces Exploration of Strategic Alternatives

SEATTLE, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals Inc. (NASDAQ:IMPL) ("Impel" or "the Company"), a commercial-stage biopharmaceutical company with a mission to develop transformative therapies for people